Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
ImmuCell Corporation (ICCC) had Free Cash Flow of $5.69M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$7.19M |
|
$1.83M |
|
$4.75M |
|
$2.44M |
|
$5.25M |
|
$1.93M |
|
$-0.05M |
|
$1.88M |
|
$1.88M |
|
$1.83M |
|
$1.83M |
|
$1.83M |
|
$1.83M |
|
$1.93M |
|
$2.41M |
|
9.06M |
|
9.19M |
|
$0.20 |
|
$0.20 |
|
| Balance Sheet Financials | |
$21.08M |
|
$21.03M |
|
$25.55M |
|
$46.63M |
|
$4.44M |
|
$6.80M |
|
$10.82M |
|
$15.26M |
|
$31.37M |
|
$31.28M |
|
$31.37M |
|
9.08M |
|
| Cash Flow Statement Financials | |
$6.59M |
|
$-0.90M |
|
$-0.64M |
|
$3.81M |
|
$8.86M |
|
$5.05M |
|
$0.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.75 |
|
-- |
|
-- |
|
0.18 |
|
0.26 |
|
33.92% |
|
26.93% |
|
26.93% |
|
-- |
|
26.17% |
|
25.53% |
|
|
Free Cash Flow |
$5.69M |
-- |
|
-- |
|
-- |
|
0.15 |
|
0.52 |
|
2.48 |
|
36.29 |
|
5.85% |
|
5.87% |
|
3.93% |
|
4.81% |
|
$3.45 |
|
$0.62 |
|
$0.72 |
|